Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study

Status Completed

Clinical Trial Summary

This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.

Clinical Trial Description

PRIMARY FEASIBILITY OBJECTIVE: I. To evaluate the feasibility of establishing a diet intervention trial with longitudinal microbiome collection in Ohio State University Comprehensive Cancer Center (OSUCCC) Lung Cancer Screening Clinic (OSUCCC-LCSC). PRIMARY SCIENTIFIC OBJECTIVE: I. To determine the impact of the black raspberry (BRB) nectar intervention on the microbiome and inflammatory biomarkers. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive BRB nectar orally (PO) twice daily (BID) for weeks 0-4 and then receive placebo PO BID for weeks 6-10 in the absence of unacceptable toxicity. Patients also undergo collection of nasal swabs, blood, urine, and stool samples at weeks 0, 4, 6, and 10. ARM II: Patients receive placebo PO BID for weeks 0-4 and then receive BRB nectar PO BID for weeks 6-10 in the absence of unacceptable toxicity. Patients also undergo collection of nasal swabs, blood, urine, and stool samples at weeks 0, 4, 6, and 10. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04267874
Study type	Interventional
Source	Ohio State University Comprehensive Cancer Center
Contact
Status	Completed
Phase	Early Phase 1
Start date	October 25, 2019
Completion date	June 13, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04931017` - Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer	Phase 2
Recruiting	`NCT05898594` - Lung Cancer Screening in High-risk Black Women	N/A
Not yet recruiting	`NCT06038526` - Evaluation of Canakinumab in High-Risk Former-Smokers	Phase 2
Terminated	`NCT02856581` - Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes	Phase 3
Completed	`NCT04922697` - Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study	N/A
Recruiting	`NCT04644952` - The Rise in Robotic Atypical Segmentectomies
Completed	`NCT01896778` - Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer	N/A
Recruiting	`NCT05407168` - Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool	N/A
Recruiting	`NCT02408861` - Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	Phase 1
Recruiting	`NCT03709953` - Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma	Phase 2
Active, not recruiting	`NCT03267524` - Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers	N/A
Recruiting	`NCT04147494` - Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues	Early Phase 1
Completed	`NCT02237183` - Iloprost in Preventing Lung Cancer in Former Smokers	Phase 1
Recruiting	`NCT04783168` - Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study	N/A
Completed	`NCT04635761` - Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening	N/A
Active, not recruiting	`NCT03164486` - First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide	Early Phase 1
Recruiting	`NCT05802186` - Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study	N/A
Active, not recruiting	`NCT01696968` - Screening for Lung Cancer in Older Patients (PLCO Screening Trial)	N/A
Recruiting	`NCT04410302` - Patient-Derived Xenografts to Reduce Cancer Health Disparities
Recruiting	`NCT04969341` - Improving Lung Cancer Screening Adherence by Overcoming Barriers for Vulnerable Populations